LONZA N overview

Lonza Group AG / Key word(s): Bond/Financing Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon 17.04.2024 / 19:00 CET/CEST Basel, Switzerland, 17 April 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a EUR 1 billion straight bond. The Eurobond marks Lonza’s second drawdown under its EMTN program. The bond has a maturity of 12 years and an annual coupon of 3.875%. The issuer is Lonza Finance...

NeuroSense Collaborates with Lonza to Identify Exosome-based Biomarkers, in order to Advance Neurodegenerative Disease Treatments and Diagnostics PR Newswire BASEL, Switzerland and CAMBRIDGE, Mass., April 9, 2024 NeuroSense will leverage its extensive experience in biomarker utilization to advance early diagnosis and treatment in the neurodegeneration field Lonza to develop, optimize, and qualify a method utilizing Neuron-Derived Exosomes ("NDEs"), set to be integrated into the clinical...

Lonza Group AG / Key word(s): Sustainability/Miscellaneous Lonza Publishes Invitation to the 2024 Annual General Meeting and 2023 Annual and Sustainability Reports 03-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Annual General Meeting will take place on 8 May 2024 at the Congress Center in Basel, Switzerland Albert M. Baehny will not stand for...

Lonza Group AG / Key word(s): Personnel Lonza Appoints Wolfgang Wienand as New Chief Executive Officer 02-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Wolfgang Wienand, currently CEO of Swiss CDMO Siegfried Holding AG, will become Chief Executive Officer of Lonza in the summer of 2024 Albert M. Baehny will retire from Lonza following a transition...

Lonza Group AG / Key word(s): Acquisition/Investment Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche 20-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) site...

Lonza Group AG / Key word(s): Personnel Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza 26-Jan-2024 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Longstanding Chairman of Lonza, Albert Baehny will not stand for re-election Jean-Marc Huët, currently Chairman of Heineken N.V. with strong international leadership track record to be proposed...

Lonza Group AG / Key word(s): Annual Results Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin 26-Jan-2024 / 06:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Robust sales of CHF 6.7 billion, delivering 10.9% 1 CER sales growth CORE EBITDA of CHF 2 billion, resulting in a margin of 29.8% Continued growth investment...